Two new iridoid glycosides from Hedyotis diffusa.

Area of Science:

• Natural Products Chemistry
• Phytochemistry
• Medicinal Chemistry

Background:

• Hedyotis diffusa Willd. is a plant used in traditional medicine.
• Iridoid glycosides are a class of natural compounds with diverse biological activities.
• Investigating the chemical constituents of Hedyotis diffusa can lead to the discovery of novel compounds.

Purpose of the Study:

• To isolate and characterize chemical constituents from Hedyotis diffusa Willd.
• To evaluate the cytotoxic activity of isolated compounds against HeLa cells.

Main Methods:

• Phytochemical investigation involving extraction and chromatographic separation techniques.
• Structure elucidation using spectroscopic methods, including 1D, 2D NMR, and HR-ESI-MS.
• Cytotoxicity assay against HeLa cancer cell line.

Main Results:

• Two new iridoid glycosides, productasperulosidic acid butyl ester (1) and E-6-O-3-hydroxy-p-methoxycinnamoyl scandoside methyl ester (2), were identified.
• Nine known iridoid glycosides (3-11) were also isolated and characterized.
• Compounds 1-11 demonstrated no significant cytotoxic activity against HeLa cells.

Conclusions:

• The study successfully identified novel and known iridoid glycosides from Hedyotis diffusa.
• The isolated compounds do not possess significant cytotoxic effects on HeLa cells, suggesting limited potential for this specific anticancer application.
• Further research may explore other biological activities of these iridoid glycosides.